OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
954457

Future Care Trading Compnay SJSC

Healthcare Facilities & ServicesVerified

Future Care Trading Company SJSC maintains a strong liquidity position, with a current ratio of 9.3, indicating a significant buffer of current assets over current liabilities. The company's liquidity_fpt metric confirms a low liquidity risk, supported by SAR 20.6 million in cash and equivalents, which represents 18.6% of total assets. The debt-to-equity ratio of 0.01 suggests a conservative capital structure with minimal leverage, aligning with the low dilution risk assessment. The company's profitability metrics are robust, with a return on equity (ROE) of 16.25% and a return on assets (ROA) of 14.23%, both exceeding the typical thresholds for healthcare service providers. Operating income of SAR 17.6 million and net income of SAR 15.8 million reflect strong operational efficiency, with a gross margin of 44.1% (SAR 33.5 million gross profit on SAR 76.1 million revenue). The company operates in a concentrated geographic and segmental structure, with all operations based in Saudi Arabia and no disclosed international revenue. The business is focused on healthcare services, with no material diversification into other sectors or product lines. This concentration may expose the company to regional economic and regulatory risks, though no immediate geopolitical pressures are flagged in the industry_config. The company's growth trajectory is positive, with a strong free cash flow of SAR 14.6 million and capital expenditures of SAR -3.7 million, indicating reinvestment in operations. While no specific revenue growth rates are provided, the company's liquidity and profitability suggest a stable and potentially expanding business model. Risk factors are minimal, with no immediate filing-based liquidity or dilution flags detected. The company's low debt-to-equity ratio and strong cash reserves reduce financial risk exposure. No dilution pressure is expected in the near term, as shares outstanding remain unchanged between basic and diluted measures. The absence of recent equity issuance or ATM/shelf registration activity supports the low dilution risk assessment. No recent filings or transcripts are available to indicate material changes in the company's operations or strategy. The company's financials and risk profile remain stable, with no disclosed events that would suggest a shift in business direction or performance.

30-day price · 9544-0.18 (-9.3%)
Low$1.74High$2.14Close$1.75As of17 May, 00:00 UTC
Profile
CompanyFuture Care Trading Compnay SJSC
Ticker9544.SE
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Future Care Trading Company SJSC provides integrated healthcare services in Saudi Arabia, including home health care, hospitals, medical clinics, and diagnostic services.

Classification. The company is classified under the Healthcare sector, specifically in the Healthcare Facilities & Services industry, with a confidence level of 0.92.

Future Care Trading Company SJSC maintains a strong liquidity position, with a current ratio of 9.3, indicating a significant buffer of current assets over current liabilities. The company's liquidity_fpt metric confirms a low liquidity risk, supported by SAR 20.6 million in cash and equivalents, which represents 18.6% of total assets. The debt-to-equity ratio of 0.01 suggests a conservative capital structure with minimal leverage, aligning with the low dilution risk assessment. The company's profitability metrics are robust, with a return on equity (ROE) of 16.25% and a return on assets (ROA) of 14.23%, both exceeding the typical thresholds for healthcare service providers. Operating income of SAR 17.6 million and net income of SAR 15.8 million reflect strong operational efficiency, with a gross margin of 44.1% (SAR 33.5 million gross profit on SAR 76.1 million revenue). The company operates in a concentrated geographic and segmental structure, with all operations based in Saudi Arabia and no disclosed international revenue. The business is focused on healthcare services, with no material diversification into other sectors or product lines. This concentration may expose the company to regional economic and regulatory risks, though no immediate geopolitical pressures are flagged in the industry_config. The company's growth trajectory is positive, with a strong free cash flow of SAR 14.6 million and capital expenditures of SAR -3.7 million, indicating reinvestment in operations. While no specific revenue growth rates are provided, the company's liquidity and profitability suggest a stable and potentially expanding business model. Risk factors are minimal, with no immediate filing-based liquidity or dilution flags detected. The company's low debt-to-equity ratio and strong cash reserves reduce financial risk exposure. No dilution pressure is expected in the near term, as shares outstanding remain unchanged between basic and diluted measures. The absence of recent equity issuance or ATM/shelf registration activity supports the low dilution risk assessment. No recent filings or transcripts are available to indicate material changes in the company's operations or strategy. The company's financials and risk profile remain stable, with no disclosed events that would suggest a shift in business direction or performance.
Key takeaways
  • Future Care Trading Company SJSC has a strong liquidity position with a current ratio of 9.3 and low debt-to-equity ratio of 0.01.
  • The company's profitability is robust, with ROE of 16.25% and ROA of 14.23%, outperforming typical healthcare service providers.
  • The business is geographically and segmentally concentrated in Saudi Arabia, with no international diversification.
  • Free cash flow of SAR 14.6 million and low capital expenditures suggest a stable and potentially expanding business model.
  • No immediate liquidity or dilution risks are flagged, with no recent equity issuance or ATM/shelf registration activity.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencySAR
Revenue$76.1M
Gross profit$33.5M
Operating income$17.6M
Net income$15.8M
R&D
SG&A
D&A
SBC
Operating cash flow$12.5M
CapEx-$3.7M
Free cash flow$14.6M
Total assets$110.7M
Total liabilities$13.7M
Total equity$97.0M
Cash & equivalents$20.6M
Long-term debt$1.4M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$97.0M
Net cash$19.2M
Current ratio9.3
Debt/Equity0.0
ROA14.2%
ROE16.2%
Cash conversion80.0%
CapEx/Revenue-4.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Biotechnology · cohort 9 companies
Metric9544Activity
Op margin23.2%11.5% medp25 9.9% · p75 15.0%top quartile
Net margin20.7%8.6% medp25 6.3% · p75 12.4%top quartile
Gross margin44.1%28.8% medp25 28.8% · p75 28.8%top quartile
CapEx / revenue-4.9%4.2% medp25 3.8% · p75 4.2%bottom quartile
Debt / equity1.0%71.3% medp25 60.7% · p75 71.3%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 22:12 UTC#d3fd9660
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 22:14 UTCJob: f98e6a60